Author: Lemaire, D.; Barbosa, T.; Rihet, P.
Title: Coping with genetic diversity: the contribution of pathogen and human genomics to modern vaccinology Document date: 2011_10_28
ID: q2y7fewk_16
Snippet: In fact, despite the amount of available data about the genome of pathogens and the human genome, the genes, molecules, and mechanisms involved in pathogen virulence or in host defense are still not clear. Understanding the mechanisms of microbial infections and the immune response against them remains a major challenge in vaccine development. This could explain why relatively slow progress has been made in the development of new efficient vaccin.....
Document: In fact, despite the amount of available data about the genome of pathogens and the human genome, the genes, molecules, and mechanisms involved in pathogen virulence or in host defense are still not clear. Understanding the mechanisms of microbial infections and the immune response against them remains a major challenge in vaccine development. This could explain why relatively slow progress has been made in the development of new efficient vaccines in spite of the emergence of high-throughput sequencing technologies and advances in bioinformatics.
Search related documents:
Co phrase search for related documents- immune response and major challenge: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36
- immune response and mechanism molecule: 1, 2
- immune response and microbial infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24
- immune response and microbial infection mechanism: 1
- immune response and pathogen virulence: 1, 2, 3, 4, 5, 6, 7
- immune response and sequencing technology: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- immune response and vaccine development: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75
- immune response and vaccine development major challenge: 1, 2
- major challenge and pathogen virulence: 1
- major challenge and sequencing technology: 1, 2, 3, 4
- major challenge and vaccine development: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33
- major challenge and vaccine development major challenge: 1, 2, 3, 4, 5, 6
- microbial infection and pathogen virulence: 1
- microbial infection and vaccine development: 1
- new efficient vaccine and vaccine development: 1
- new efficient vaccine development and vaccine development: 1
- pathogen virulence and sequencing technology: 1
- pathogen virulence and vaccine development: 1, 2, 3
- sequencing technology and vaccine development: 1, 2, 3, 4, 5
Co phrase search for related documents, hyperlinks ordered by date